EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities

Chan Zou, Shilong Jiang, Hui Li, Kai Zhao, Dongshen Cao, Guoping Yang iD

MedComm · 2026-03 · 7 (3)

DOI: 10.1002/mco2.70660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 05.03.2026. Verfasst von Chan Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center For Clinical Pharmacology Third Xiangya Hospital Central South University Changsha China. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NLRP3 inflammasome is a pivotal signaling platform of the innate immune system that senses a broad spectrum of microbial, metabolic, and environmental danger signals. Its activation leads to the recruitment of ASC and caspase‐1, driving the maturation of pro‐inflammatory cytokines interleukin (IL)‐1β and IL‐18 as well as the execution of pyroptosis. Aberrant or persistent activation of NLRP3 has been implicated in the pathogenesis of numerous disorders, including autoinflammatory syndromes, metabolic and cardiovascular diseases, neurodegenerative conditions, and cancers. In this review, we provide an updated overview of the molecular mechanisms governing NLRP3 activation and regulation, with particular focus on ion flux, mitochondrial damage, lysosomal rupture, reactive oxygen species, and post‐translational modifications. We further discuss negative regulatory pathways that maintain inflammasome homeostasis and prevent excessive inflammation. Finally, we summarize recent advances in therapeutic strategies targeting the NLRP3 inflammasome, ranging from direct inhibitors and allosteric modulators to biologics and repurposed drugs, and highlight their translational potential. Understanding the fine balance between NLRP3 activation and inhibition offers new opportunities for therapeutic intervention in a wide array of inflammatory and immune‐related diseases.

Schlagwörter

Stichwörter der Autor:innen

NLRP3 inflammasomeactivation mechanismsinflammatory diseasesinnate immunitytherapeutic inhibitors

Autor:innen und Institutionen

  • Center For Clinical Pharmacology Third Xiangya Hospital Central South University Changsha China.
  • Department of Pharmacy Xiangya Hospital Central South University Changsha China.
  • The Hunan Institute of Pharmacy Practice and Clinical Research Changsha China.
  • National Clinical Research Center for Geriatric Disease Xiangya Hospital Central South University Changsha China.
  • Xiangya School of Pharmaceutical Science Central South University Changsha China.
  • Department of Hematology and Critical Care Medicine the Third Xiangya Hospital Central South University Changsha China.

ORCID-Profile: Guoping Yang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Zou, C., Jiang, S., Li, H., Zhao, K., Cao, D., & Yang, G. (2026). The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. MedComm, 7(3). https://doi.org/10.1002/mco2.70660

Vancouver

Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G. The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. MedComm. 2026;7(3). doi:10.1002/mco2.70660

BibTeX
@article{Zou2026,
  author = {Zou, Chan and Jiang, Shilong and Li, Hui and Zhao, Kai and Cao, Dongshen and Yang, Guoping},
  title = {The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/mco2.70660}
}
Kostenlos starten →